Clinical Trial Update: Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the use of tirofiban and a paclitaxel-eluting stent during postfibrinolysis angioplasty in patients with myocardial infarction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Paclitaxel-eluting stent (paclitaxel-eluting stent)
• tirofiban (tirofiban)

Snippet

Sponsor: GRACIA Group | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED